2026 American Society of Clinical Oncology (ASCO) Annual MeetingInhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC (ASCO 2026 Ozekibart in CRC Updated Data[...]

Inhibrx Biosciences Inc. published this content on April 16, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 30, 2026 at 04:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]